upper gi regimens - comment on existing regimen Please complete this form and submit your comments or amendments Your Details: Your Name: Your Email:   Regimen Details: Upper GI Regimen: Choose One Capecitabine ( v1.0 - Upper GI - Oesopho-gastric Junction - 1st / subsequent metastatic) Capecitabine ( v1.0 - Upper GI - Gastric - 1st and subsequent line metastatic) Capecitabine ( v1.0 - Upper GI - Oesophageal - 1st and subsequent line metastatic) CF ( v1.0 - Upper GI - Oesophageal - 1st and subsequent line metastatic) CF ( v1.0 - Upper GI - Oesopho-gastric Junction - 1st / subsequent metastatic) CF ( v1.0 - Upper GI - Gastric - 1st and subsequent line metastatic) Cisplatin / 5-FU (4day) ( v1.0 - Upper GI - Oesophageal - Neo-adjuvant) CX ( v1.0 - Upper GI - Oesophageal - 1st and subsequent line metastatic) CX ( v1.0 - Upper GI - Oesopho-gastric Junction - 1st / subsequent metastatic) CX ( v1.0 - Upper GI - Gastric - 1st and subsequent line metastatic) Docetaxel ( v1.0 - Upper GI - Oesopho-gastric Junction - 2nd line metastatic) Docetaxel ( v1.0 - Upper GI - Gastric - 2nd line metastatic) Docetaxel ( v1.0 - Upper GI - Oesophageal - 2nd line metastatic) Docetaxel - Weekly ( v1.0 - Upper GI - Oesopho-gastric Junction - 2nd line metastatic) Docetaxel - Weekly ( v1.0 - Upper GI - Gastric - 2nd line metastatic) Docetaxel - Weekly ( v1.0 - Upper GI - Oesophageal - 2nd line metastatic) ECF ( v1.0 - Upper GI - Gastric - 1st and subsequent line metastatic) ECF ( v1.0 - Upper GI - Oesophageal - 1st and subsequent line metastatic) ECF ( v1.0 - Upper GI - Oesopho-gastric Junction - Neo-adjuvant) ECF ( v1.0 - Upper GI - Oesopho-gastric Junction - Adjuvant) ECF ( v1.0 - Upper GI - Oesopho-gastric Junction - 1st / subsequent metastatic) ECF ( v1.0 - Upper GI - Gastric - Neo-ajuvant) ECF ( v1.0 - Upper GI - Gastric - Adjuvant) ECX ( v1.0 - Upper GI - Oesopho-gastric Junction - Neo-adjuvant) ECX ( v1.0 - Upper GI - Oesopho-gastric Junction - Adjuvant) ECX ( v1.0 - Upper GI - Oesopho-gastric Junction - 1st / subsequent metastatic) ECX ( v1.0 - Upper GI - Gastric - Neo-ajuvant) ECX ( v1.0 - Upper GI - Gastric - Adjuvant) ECX ( v1.0 - Upper GI - Gastric - 1st and subsequent line metastatic) ECX ( v1.0 - Upper GI - Oesophageal - 1st and subsequent line metastatic) EOX ( v1.0 - Upper GI - Oesophageal - 1st and subsequent line metastatic) EOX ( v1.0 - Upper GI - Oesopho-gastric Junction - 1st / subsequent metastatic) EOX ( v1.0 - Upper GI - Gastric - 1st and subsequent line metastatic) EOX - low dose ( v1.0 - Upper GI - Gastric - 2nd line metastatic) EOX - low dose ( v1.0 - Upper GI - Oesophageal - 2nd line metastatic) EOX - low dose ( v1.0 - Upper GI - Oesopho-gastric Junction - 2nd line metastatic) Irinotecan - weekly ( v1.0 - Upper GI - Gastric - 2nd line metastatic) Irinotecan - weekly ( v1.0 - Upper GI - Oesophageal - 2nd line metastatic) Irinotecan - weekly ( v1.0 - Upper GI - Oesopho-gastric Junction - 2nd line metastatic) Irinotecan / Capecitabine - 2 Weekly ( v1.0 - Upper GI - Oesophageal - 2nd line metastatic) Irinotecan / Capecitabine - 2 Weekly ( v1.0 - Upper GI - Oesopho-gastric Junction - 2nd line metastatic) Irinotecan / Capecitabine - 2 Weekly ( v1.0 - Upper GI - Gastric - 2nd line metastatic) Modified De Gramont ( v1.0 - Upper GI - Oesophageal - 1st and subsequent line metastatic) Modified De Gramont ( v1.0 - Upper GI - Oesopho-gastric Junction - 1st / subsequent metastatic) Modified De Gramont ( v1.0 - Upper GI - Gastric - 1st and subsequent line metastatic) OX ( v1.0 - Upper GI - Gastric - 1st and subsequent line metastatic) OX ( v1.0 - Upper GI - Oesophageal - 1st and subsequent line metastatic) OX ( v1.0 - Upper GI - Oesopho-gastric Junction - 1st / subsequent metastatic) Comments:

	Chemotherapy
	Adult regimens
	Upper GI regimens